| |
| |
|
| |
|
|
| |
Progenitor International Research offers in-depth therapeutic expertise to maximize your drug development programs. Our key scientists, medical affairs and pharmacovigilance professionals, clinical and laboratory leaders, management teams, and many of our team members bring advanced degrees with expertise both in their local market and in Western medicine. Our collective experience includes over 500 studies in the last 5 years and multiple success stories in the below therapeutic areas:
|
|
| |
| |
|
| |
Cardiovascular Disease |
| |
Critical Care |
| |
CNS (neurology, psychiatry and pain) |
| |
Dermatology |
| |
Generic Drug Development |
| |
Gastrointestinal Disorders |
| |
Immunology |
| |
Infectious Disease |
| |
Oncology |
| |
Respiratory Disease |
| |
Sexual Dysfunction |
| |
Women’s Health |
| |
Preclinical Experience |
| |
Contract Manufacturing of Biologicals |
| |
|
| If there is a specific therapeutic area, delivery system, or special patient population that you are interested in that is not listed above, please contact us for more information. |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
When timelines are critical, who you know and how you relate culturally is important. Relationships with investigators, knowledge of ethics committees and regulatory agencies in these local environments are cornerstones to the
success of your project. Investigators look to our colleagues as respected research professionals on the drug development frontier. Experience with regulatory agencies and ethics committees, an in-depth knowledge of the processes, timelines and requirements for successful approval all translate into an optimized study start for your program.
|
|
|
| |
|
|
|